Medical Tourism on the Rise in Turkey
With the construction of state-of-the-art public and private hospitals, Turkey is poised to become a global leader in medical tourism. Turkey has always been a popular tourist destination, given…
Turkey’s Localisation Policy: From Consumption to Production
In 2016 the Turkish Medicine and Medical Devices Agency (TiTCK) implemented a localisation policy to reduce Turkey’s reliance on imports – a few years later, it has created a young,…
Algeria: The Middle Eastern Investment Wave
Key recent investments from Middle Eastern companies into Algerian Pharma. Saudi company Tabuk Pharmaceuticals invests USD 20 million into a plant in Blida (2014) “We arrived in Algeria in…
Algeria: The Scramble to Localise
A sudden imposition of import restrictions on pharmaceuticals in 2017 has pushed several multinational companies to establish local production facilities in Algeria. However, the localization process can be fraught both…
Algeria scraps plans for new hospitals, denting investor confidence
The global drop in oil prices in 2015-2016 hit the Algerian economy – which is heavily reliant on petroleum revenues – hard. The country’s government implemented severe economic cuts across…
Algeria: A market not to be underestimated
Multinational pharmaceutical companies are increasingly choosing Algeria as a base for their regional headquarters, despite the complexities of the local market. The representatives of Lilly, bioMérieux and Abbott in Algeria…
Flouting IP to deliver cheap Hep C drugs
With non WTO members such as Algeria flouting intellectual property (IP) it raises the issue of how best to protect and price medicines in the future. In a fascinating interview…
Turkey’s Talent Hope
With its current turbulent economic and political climate, Turkey is betting its future prosperity on 2 key aspects – its young talent pool and its location as an intersection between…
Turkey: The Future of Cancer Care Uncertain
Turkey has one of the most revered Social Security Systems in the world, providing its citizens with free healthcare and access to a long list of innovative cancer drugs. However, with one…
Top Causes of Death in Algeria
A confluence of factors – urbanisation, industrialisation, poor eating habits and a sedentary lifestyle – have triggered a surge in noncommunicable diseases (NCDs) in Algeria. NCDs now account for 76…
Tunisia: Diabetes on the Rise
Diabetes is an important problem in Tunisia, with prevalence is expected to increase over the coming years. Jean-Francois Courtet, general manager of Novo Nordisk in Tunisia, points out rgar “diabetes…
Tunisia: A New Framework for Biotech Investments
The long-awaited conference marking the launch of the company cluster of Sidi Thabet (a city in the governorate of Ariana, 20 minutes from Tunis airport) took place on September 28th…